BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30414949)

  • 1. Characterization of the thymus in Lrp4 myasthenia gravis: Four cases.
    Koneczny I; Rennspiess D; Marcuse F; Dankerlui N; Abdul Hamid M; Mané-Damas M; Maessen J; Van Schil P; Saxena A; Zisimopoulou P; Lazaridis K; Woodhall M; Karagiorgou K; Tzartos J; Tzartos S; De Baets MH; Molenaar PC; Marx A; Zur Hausen A; Losen M; Martinez-Martinez P
    Autoimmun Rev; 2019 Jan; 18(1):50-55. PubMed ID: 30414949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
    J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
    Ohta R; Motomura M
    Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress of myasthenia gravis: discovery of Lrp4 antibodies].
    Motomura M; Higuchi O
    Rinsho Shinkeigaku; 2012; 52(11):1303-5. PubMed ID: 23196599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
    Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L
    Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Double Seronegative Myasthenia Gravis: A Systematic Review.
    Bacchi S; Kramer P; Chalk C
    Can J Neurol Sci; 2018 Jan; 45(1):62-67. PubMed ID: 29334041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
    Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
    PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.
    Nikolic AV; Bojic SD; Rakocevic Stojanovic VM; Basta IZ; Lavrnic DV
    Eur J Neurol; 2016 Nov; 23(11):1635-1641. PubMed ID: 27415961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.
    Shen C; Lu Y; Zhang B; Figueiredo D; Bean J; Jung J; Wu H; Barik A; Yin DM; Xiong WC; Mei L
    J Clin Invest; 2013 Dec; 123(12):5190-202. PubMed ID: 24200689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma.
    Ishikawa H; Taniguchi A; Ii Y; Higuchi O; Matsuo H; Nakane S; Asahi M; Niwa A; Tomimoto H
    Neuromuscul Disord; 2017 Oct; 27(10):914-917. PubMed ID: 28694075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies in myasthenia gravis].
    Motomura M; Narita Masuda T
    Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
    Berrih-Aknin S; Le Panse R
    Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double seronegative myasthenia gravis with anti-LRP 4 antibodies.
    Zouvelou V; Zisimopoulou P; Rentzos M; Karandreas N; Evangelakou P; Stamboulis E; Tzartos SJ
    Neuromuscul Disord; 2013 Jul; 23(7):568-70. PubMed ID: 23768983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
    Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
    Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.